Drug recall
ACETYLCYSTEINE OPTH 10% Solution, 15 mL droptainers, Rx only, Vital Care Compounder, 115 S. 40th Ave…
FDA recall event 90982 · Class II · Pharmacy Plus, Inc. dba Vital Care Compounder
Key facts
| Event ID | 90982 |
|---|---|
| Recall numbers | D-0026-2023, D-0027-2023, D-0028-2023, D-0029-2023, D-0030-2023, D-0031-2023, D-0032-2023, D-0033-2023, D-0034-2023, D-0035-2023, D-0036-2023, D-0037-2023 and 20 more |
| Recalling firm | Pharmacy Plus, Inc. dba Vital Care Compounder |
| Product type | Drugs |
| Products | ACETYLCYSTEINE OPTH 10% Solution, 15 mL droptainers, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402, ACETYLCYSTEINE OPTH 5% Solution, 15 mL droptainers, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402, AUTOLOGUS TEARS SERUM SOLN FULL STRENGTH, 3 mL droptainers, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402, BRILLIANT BLUE G, 0.04% Solution, 2 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402, CEFTAZIDIME INTRAVITREAL 2.25MG/0.1ML Solution, 0.5 mL syringe, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402 and 27 more |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile. |
| Initiation date | Oct 7, 2022 |
| Report date | Nov 9, 2022 |
| City | Hattiesburg |
| State | MS |
| Country | United States |
| FEI number | 3010241801 |
At a glance
- 10–99 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: